As of 2026-03-31, 聚焦肝病治疗领域药物's data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 0.00%, above the industry average by 0.0 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 聚焦肝病治疗领域药物's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
聚焦肝病治疗领域药物's Mention Rate is 0.00%, lower than 0.6% of competitors
聚焦肝病治疗领域药物's First Mention is 0.00%, lower than 0.9% of competitors
聚焦肝病治疗领域药物's Preferred Rate is 0.00%, lower than 100.0% of competitors
聚焦肝病治疗领域药物's Positive Rate is 0.00%, lower than 8.9% of competitors
聚焦肝病治疗领域药物's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 王王老吉凉茶 | 0% | 0% | 0% | 0% | 0% | View Details |
| 同同仁牛黄清心丸 | 0% | 0% | 0% | 0% | 0% | View Details |
| 云云南白药系列 | 0% | 0% | 0% | 0% | 0% | View Details |
| 感感冒、胃肠、皮肤、骨科用药 | 0% | 0% | 0% | 0% | 0% | View Details |
| 抗抗疟药物 | 0% | 0% | 0% | 0% | 0% | View Details |
| 全全生命周期管线布局产品 | 0% | 0% | 0% | 0% | 0% | View Details |
| 聚聚焦肝病治疗领域药物 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
